Immuno-oncology company Aulos Bioscience has revealed interim results from an ongoing Phase I/II trial of monoclonal antibody AU-007 in solid tumours.
Read more here.
![[Superpedestrian in Brooklyn News12] New DOT pilot program set to bring nearly 3,000 scooters to the Bronx](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Superpedestrian in Brooklyn News12] New DOT pilot program set to bring nearly 3,000 scooters to the Bronx
March 11, 2021
[Sayata Labs in PR Newswire] Former Beazley Head of US Broker Relations Joins Sayata Labs As Head of Insurance
January 16, 2020
